Introduction and Definition Awareness of Deficit (AoD) following Acquired Brain Injury (ABI) represents a complex neuropsychological phenomenon wherein an individual exhibits diminished insight into the nature, extent, or implications of the cognitive, physical, or behavioral impairments resulting from neurological damage. This lack of awareness is a critical factor influencing recovery trajectories and is distinct from […]
Definition and Scope of Acute Brain Dysfunction Acute Brain Dysfunction (ABD) designates a severe, rapid-onset neurological disorder characterized by profound alterations in attention, consciousness, and cognition, representing an urgent medical and neurological emergency. It is fundamentally distinct from chronic neurodegenerative processes because its onset is typically measured in hours or days, demanding immediate clinical intervention […]
Defining Adult Intellectual Disability Adult Intellectual Disability (AID) is characterized by significant limitations in both intellectual functioning and in adaptive behavior, originating before the age of 18. This definition, adopted by major diagnostic systems such as the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and the World Health Organization’s International Classification […]
Introduction to Alcohol and Behavioral Pharmacology Ethanol, the psychoactive component in alcoholic beverages, is fundamentally classified as a central nervous system depressant, yet its behavioral effects are complex and often biphasic, meaning that low doses may produce subjective stimulation while higher doses invariably lead to sedation and significant impairment. Understanding the behavioral effects of drinking […]
Introduction to ALS and Cognitive Impairment Amyotrophic Lateral Sclerosis (ALS) is historically recognized as a relentlessly progressive neurodegenerative disorder primarily affecting the motor system, leading to the degeneration of upper and lower motor neurons. This degeneration results in progressive muscle weakness, atrophy, and eventual respiratory failure. For decades, the prevailing clinical view adhered to the […]
Introduction to Behavioral Phenotypes in Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis (ALS) is traditionally understood as a devastating neurodegenerative condition characterized primarily by the progressive loss of motor neurons, leading to muscle weakness, atrophy, and eventual respiratory failure. However, contemporary research has decisively expanded this definition, recognizing that ALS exists along a spectrum of disease […]
Introduction to Alzheimer’s Dementia as a Disabling Condition Alzheimer’s Dementia (AD) is recognized not merely as a memory disorder but fundamentally as a severe, progressive, and terminal disabling condition that systematically erodes cognitive function, behavioral regulation, and physical independence. It stands as the most prevalent cause of dementia globally, characterized pathologically by the accumulation of […]
Defining the Severity Continuum in Alzheimer’s Dementia Alzheimer’s Dementia (AD) represents a progressive neurodegenerative disorder characterized by insidious onset and continuous decline in cognitive and functional capacity. The assessment of disability severity in AD is not merely a clinical curiosity but is fundamental for accurate diagnosis, prognostic forecasting, ethical decision-making regarding treatment efficacy, and, most […]
Introduction to Alzheimer‐Type Dementia Disability Alzheimer-Type Dementia Disability (ATDD) represents the profound functional decline resulting from Alzheimer’s disease (AD), a progressive neurodegenerative disorder characterized by irreversible cognitive deterioration. While Alzheimer’s disease describes the underlying pathology and primary disease state, ATDD specifically addresses the resulting inability to perform necessary life functions, transitioning the condition from a […]
Introduction to the Alzheimer’s Disease Clinical Global Impression of Change The Alzheimer’s Disease Clinical Global Impression of Change (ADCS-CGIC) is a crucial, high-stakes instrument utilized globally in clinical trials designed to evaluate the efficacy of novel therapeutic agents targeting Alzheimer’s disease (AD). Unlike purely objective cognitive assessments, which measure specific domains such as memory recall […]